Lex: premium commentary

Lex is the FT’s premium daily business and finance column. It is the oldest and arguably the most influential column of its kind. Writers in London, New York, San Francisco and Hong Kong highlight global risks and opportunities with wit and brevity. 

Flurry of expansion has come at a cost to revenue growth

Plans to reduce a dependence on gaming make sense

Disposal of medical devices unit will be a shot in the arm for the conglomerate

Private companies are, in many ways, better off than public ones

Earnings report suggests group is just having growing pains

Greater exposure of operating performance is long overdue